OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging biomarkers in Multiple Myeloma: A review
Nidhi Gupta, Aparna Sharma, Alpana Sharma
Clinica Chimica Acta (2019) Vol. 503, pp. 45-53
Closed Access | Times Cited: 59
Nidhi Gupta, Aparna Sharma, Alpana Sharma
Clinica Chimica Acta (2019) Vol. 503, pp. 45-53
Closed Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 134
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 134
Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
Qiang Cao, Xinyan Wu, Qi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Qiang Cao, Xinyan Wu, Qi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2019–2020
David J. Harvey
Mass Spectrometry Reviews (2022) Vol. 42, Iss. 5, pp. 1984-2206
Open Access | Times Cited: 23
David J. Harvey
Mass Spectrometry Reviews (2022) Vol. 42, Iss. 5, pp. 1984-2206
Open Access | Times Cited: 23
Liquid biopsy in hematological malignancies: current and future applications
Donatella Talotta, Mohammad Almasri, Chiara Cosentino, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Donatella Talotta, Mohammad Almasri, Chiara Cosentino, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Development Trends in the Clinical Test of Multiple Myeloma from 2000 to 2023: A Bibliometric Study
Hongcheng Wu, Haomiao Sun, Yichen Wang, et al.
(2025)
Closed Access
Hongcheng Wu, Haomiao Sun, Yichen Wang, et al.
(2025)
Closed Access
Detection of circulating plasma cells in peripheral blood using deep learning‐based morphological analysis
Pu Chen, Lan Zhang, Xinyi Cao, et al.
Cancer (2024) Vol. 130, Iss. 10, pp. 1884-1893
Open Access | Times Cited: 4
Pu Chen, Lan Zhang, Xinyi Cao, et al.
Cancer (2024) Vol. 130, Iss. 10, pp. 1884-1893
Open Access | Times Cited: 4
Construction of the prognostic model for small‐cell lung cancer based on inflammatory markers: A real‐world study of 612 cases with eastern cooperative oncology group performance score 0–1
Chang Liu, Bo Jin, Yunpeng Liu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 9527-9540
Open Access | Times Cited: 10
Chang Liu, Bo Jin, Yunpeng Liu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 9527-9540
Open Access | Times Cited: 10
Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients
Maria Papatsirou, Christos K. Kontos, Ioannis Ntanasis‐Stathopoulos, et al.
HemaSphere (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Maria Papatsirou, Christos K. Kontos, Ioannis Ntanasis‐Stathopoulos, et al.
HemaSphere (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
SRRM2 may be a potential biomarker and immunotherapy target for multiple myeloma: a real-world study based on flow cytometry detection
Jinjing Guo, Zhiye Zhang, Huiping Wang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Jinjing Guo, Zhiye Zhang, Huiping Wang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy
Sean Bujarski, Kyle A. Udd, Camilia Soof, et al.
Targeted Oncology (2021) Vol. 16, Iss. 4, pp. 503-515
Closed Access | Times Cited: 15
Sean Bujarski, Kyle A. Udd, Camilia Soof, et al.
Targeted Oncology (2021) Vol. 16, Iss. 4, pp. 503-515
Closed Access | Times Cited: 15
CircRNA circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma
Lin Liu, Feng Zhang, Jiajia Li
Hematology (2021) Vol. 26, Iss. 1, pp. 716-723
Open Access | Times Cited: 15
Lin Liu, Feng Zhang, Jiajia Li
Hematology (2021) Vol. 26, Iss. 1, pp. 716-723
Open Access | Times Cited: 15
Recent advances in nanoscale materials for antibody-based cancer theranostics
Deepak Kukkar, Preeti Kukkar, Vanish Kumar, et al.
Biosensors and Bioelectronics (2020) Vol. 173, pp. 112787-112787
Closed Access | Times Cited: 15
Deepak Kukkar, Preeti Kukkar, Vanish Kumar, et al.
Biosensors and Bioelectronics (2020) Vol. 173, pp. 112787-112787
Closed Access | Times Cited: 15
A Low Albumin-to-Globulin Ratio Predicts a Poor Prognosis in Patients With Metastatic Non-small-cell Lung Cancer
Ping Lü, Yifei Ma, Shaozhong Wei, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 13
Ping Lü, Yifei Ma, Shaozhong Wei, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 13
Association between albumin-to-globulin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study
Jinzhan Chen, Congyi Xie, Yimin Yang, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Jinzhan Chen, Congyi Xie, Yimin Yang, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
DAZAP1 facilitates the alternative splicing of KITLG to promote multiple myeloma cell proliferation via ERK signaling pathway
Yanyan Zhou, Shaohua Huangfu, Muxi Li, et al.
Aging (2022) Vol. 14, Iss. 19, pp. 7972-7985
Open Access | Times Cited: 8
Yanyan Zhou, Shaohua Huangfu, Muxi Li, et al.
Aging (2022) Vol. 14, Iss. 19, pp. 7972-7985
Open Access | Times Cited: 8
Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma
Maiia Soloveva, M. V. Solovev, Natalya Risinskaya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9426-9426
Open Access | Times Cited: 1
Maiia Soloveva, M. V. Solovev, Natalya Risinskaya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9426-9426
Open Access | Times Cited: 1
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature
Paraskevi Karousi, Αριστέα-Μαρία Παπανώτα, Pinelopi I. Artemaki, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1811-1811
Open Access | Times Cited: 10
Paraskevi Karousi, Αριστέα-Μαρία Παπανώτα, Pinelopi I. Artemaki, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1811-1811
Open Access | Times Cited: 10
Molecular markers in cancer
Ejaj Ahmad, Asgar Ali, Nimisha, et al.
Clinica Chimica Acta (2022) Vol. 532, pp. 95-114
Closed Access | Times Cited: 7
Ejaj Ahmad, Asgar Ali, Nimisha, et al.
Clinica Chimica Acta (2022) Vol. 532, pp. 95-114
Closed Access | Times Cited: 7
The identification of novel stroke-related sphingolipid biomarkers using UPLC-MS/MS
Zhi Yang, Xuhui Deng, Jinhua Zhu, et al.
Clinica Chimica Acta (2023) Vol. 552, pp. 117652-117652
Closed Access | Times Cited: 3
Zhi Yang, Xuhui Deng, Jinhua Zhu, et al.
Clinica Chimica Acta (2023) Vol. 552, pp. 117652-117652
Closed Access | Times Cited: 3
Proteomics analysis of serum and urine identifies VCP and CTSA as potential biomarkers associated with multiple myeloma
Wenxuan Fu, Yichuan Song, Rui Zhao, et al.
Clinica Chimica Acta (2023) Vol. 552, pp. 117701-117701
Closed Access | Times Cited: 3
Wenxuan Fu, Yichuan Song, Rui Zhao, et al.
Clinica Chimica Acta (2023) Vol. 552, pp. 117701-117701
Closed Access | Times Cited: 3
Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling
Nidhi Gupta, Raman Kumar, Alpana Sharma
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 6, pp. 2551-2559
Closed Access | Times Cited: 7
Nidhi Gupta, Raman Kumar, Alpana Sharma
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 6, pp. 2551-2559
Closed Access | Times Cited: 7
Integrative analysis of enrichment and prognostic value of ferroptosis-related genes and pathways in multiple myeloma
Qi Su, Qi Li, Weimin Zhang, et al.
Carcinogenesis (2022) Vol. 43, Iss. 11, pp. 1050-1058
Closed Access | Times Cited: 5
Qi Su, Qi Li, Weimin Zhang, et al.
Carcinogenesis (2022) Vol. 43, Iss. 11, pp. 1050-1058
Closed Access | Times Cited: 5
Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma
Dollapak Apipongrat, Sittiruk Roytrakul, Kannadit Prayongratana, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278464-e0278464
Open Access | Times Cited: 5
Dollapak Apipongrat, Sittiruk Roytrakul, Kannadit Prayongratana, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278464-e0278464
Open Access | Times Cited: 5
High expression of HOXC6 predicts a poor prognosis and induces proliferation and inflammation in multiple myeloma cells
Zhihua Li, Yaru Wang, Xiaoxu Hou, et al.
Genes & Genomics (2023) Vol. 45, Iss. 7, pp. 945-955
Closed Access | Times Cited: 2
Zhihua Li, Yaru Wang, Xiaoxu Hou, et al.
Genes & Genomics (2023) Vol. 45, Iss. 7, pp. 945-955
Closed Access | Times Cited: 2
